Shannon M Bates1, Roman Jaeschke2, Scott M Stevens3, Steven Goodacre4, Philip S Wells5, Matthew D Stevenson4, Clive Kearon2, Holger J Schunemann2, Mark Crowther6, Stephen G Pauker7, Regina Makdissi8, Gordon H Guyatt2. 1. Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada. Electronic address: batesm@mcmaster.ca. 2. Departments of Medicine and Clinical Epidemiology and Biostatistics, McMaster University, Hamilton, ON, Canada. 3. Department of Medicine, Intermountain Medical Center, Murray, UT. 4. School of Health and Related Research, University of Sheffield, Sheffield, England. 5. Department of Medicine, University of Ottawa, Ottawa, ON, Canada. 6. Department of Medicine, McMaster University and Thrombosis and Atherosclerosis Research Institute, Hamilton, ON, Canada. 7. Department of Medicine, Tufts New England Medical Center, Boston, MA. 8. Department of Medicine, University of Buffalo, Buffalo, NY.
Abstract
BACKGROUND: Objective testing for DVT is crucial because clinical assessment alone is unreliable and the consequences of misdiagnosis are serious. This guideline focuses on the identification of optimal strategies for the diagnosis of DVT in ambulatory adults. METHODS: The methods of this guideline follow those described in Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. RESULTS: We suggest that clinical assessment of pretest probability of DVT, rather than performing the same tests in all patients, should guide the diagnostic process for a first lower extremity DVT (Grade 2B). In patients with a low pretest probability of first lower extremity DVT, we recommend initial testing with D-dimer or ultrasound (US) of the proximal veins over no diagnostic testing (Grade 1B), venography (Grade 1B), or whole-leg US (Grade 2B). In patients with moderate pretest probability, we recommend initial testing with a highly sensitive D-dimer, proximal compression US, or whole-leg US rather than no testing (Grade 1B) or venography (Grade 1B). In patients with a high pretest probability, we recommend proximal compression or whole-leg US over no testing (Grade 1B) or venography (Grade 1B). CONCLUSIONS: Favored strategies for diagnosis of first DVT combine use of pretest probability assessment, D-dimer, and US. There is lower-quality evidence available to guide diagnosis of recurrent DVT, upper extremity DVT, and DVT during pregnancy.
BACKGROUND: Objective testing for DVT is crucial because clinical assessment alone is unreliable and the consequences of misdiagnosis are serious. This guideline focuses on the identification of optimal strategies for the diagnosis of DVT in ambulatory adults. METHODS: The methods of this guideline follow those described in Methodology for the Development of Antithrombotic Therapy and Prevention of Thrombosis Guidelines: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. RESULTS: We suggest that clinical assessment of pretest probability of DVT, rather than performing the same tests in all patients, should guide the diagnostic process for a first lower extremity DVT (Grade 2B). In patients with a low pretest probability of first lower extremity DVT, we recommend initial testing with D-dimer or ultrasound (US) of the proximal veins over no diagnostic testing (Grade 1B), venography (Grade 1B), or whole-leg US (Grade 2B). In patients with moderate pretest probability, we recommend initial testing with a highly sensitive D-dimer, proximal compression US, or whole-leg US rather than no testing (Grade 1B) or venography (Grade 1B). In patients with a high pretest probability, we recommend proximal compression or whole-leg US over no testing (Grade 1B) or venography (Grade 1B). CONCLUSIONS: Favored strategies for diagnosis of first DVT combine use of pretest probability assessment, D-dimer, and US. There is lower-quality evidence available to guide diagnosis of recurrent DVT, upper extremity DVT, and DVT during pregnancy.
Authors: Wee-Shian Chan; Sanjeev Chunilal; Agnes Lee; Mark Crowther; Marc Rodger; Jeffrey S Ginsberg Journal: Ann Intern Med Date: 2007-08-07 Impact factor: 25.391
Authors: Colin Patrick Cantwell; Andrea Cradock; John Bruzzi; Patricia Fitzpatrick; Stephen Eustace; John G Murray Journal: J Vasc Interv Radiol Date: 2006-11 Impact factor: 3.464
Authors: Roderik A Kraaijenhagen; Franco Piovella; Enrico Bernardi; Fabio Verlato; Erik A M Beckers; Maria M W Koopman; Marisa Barone; Giuseppe Camporese; Bert Jan Potter Van Loon; Martin H Prins; Paolo Prandoni; Harry R Büller Journal: Arch Intern Med Date: 2002-04-22
Authors: M A Bettmann; E W Salzman; D Rosenthal; P Clagett; G Davies; R Nebesar; K Rabinov; J Ploetz; J Skillman Journal: AJR Am J Roentgenol Date: 1980-06 Impact factor: 3.959
Authors: Shannon M Bates; Ian A Greer; Saskia Middeldorp; David L Veenstra; Anne-Marie Prabulos; Per Olav Vandvik Journal: Chest Date: 2012-02 Impact factor: 9.410
Authors: Gordon H Guyatt; Elie A Akl; Mark Crowther; Holger J Schünemann; David D Gutterman; Sandra Zelman Lewis Journal: Chest Date: 2012-02 Impact factor: 9.410
Authors: David Liu; Erica Peterson; James Dooner; Mark Baerlocher; Leslie Zypchen; Joel Gagnon; Michael Delorme; Chad Kim Sing; Jason Wong; Randolph Guzman; Gavin Greenfield; Otto Moodley; Paul Yenson Journal: CMAJ Date: 2015-09-28 Impact factor: 8.262
Authors: Clive Kearon; Elie A Akl; Anthony J Comerota; Paolo Prandoni; Henri Bounameaux; Samuel Z Goldhaber; Michael E Nelson; Philip S Wells; Michael K Gould; Francesco Dentali; Mark Crowther; Susan R Kahn Journal: Chest Date: 2012-02 Impact factor: 9.410
Authors: Julia R Coleman; Annika B Kay; Ernest E Moore; Hunter B Moore; Eduardo Gonzalez; Sarah Majercik; Mitchell J Cohen; Thomas White; Fredric M Pieracci Journal: Am J Surg Date: 2019-09-10 Impact factor: 2.565